Interviews with Kirollos Hanna, PharmD, BCPS, BCOP, of Minnesota Oncology and Mayo Clinic College of Medicine, and Alti Rahman, MHA, MBA, of American Oncology Network, from day 1 of the Association of Cancer Care Centers 50th Annual Meeting & Cancer Center Business Summit (ACCC AMCCBS).
You can stream day 2 at 7 pm EST on March 1.
The American Journal of Managed Care® (AJMC®) is on site in Washington, DC, at the Association of Cancer Care Centers' (ACCC) 50th Annual Meeting & Cancer Center Business Summit.
We will be recapping some of the top information presented each day at the conference. But first, competition in community oncology took another turn today with the merger of two entities, the National Cancer Care Alliance (NCCA) and the Quality Cancer Care Alliance (QCCA).
The new organization, called ONCare Alliance, will be led by 2 of the leading women in community oncology, cochairs Barbara McAneny, MD, of the New Mexico Cancer Center, the founder of NCCA, and Sibel Blau, MD, of Northwest Medical Specialties of Puyallup, Washington, who was the CEO of QCCA.
The union of the 2 smaller independent practice groups comes as 2 other community oncology organizations, OneOncology and The US Oncology Network, continue to add practices to thrive in an increasingly competitive marketplace, amid challenges such as drug shortages and new regulatory requirements. For more, read our coverage.
On day 1, Hayden Klein, associate editor at AJMC, spoke with Kirollos Hanna, PharmD, BCPS, BCOP, director of pharmacy at Minnesota Oncology and assistant professor of pharmacy at Mayo Clinic College of Medicine, about his session on payer, manufacturer, and supply chain challenges in oncology. In this exclusive interview, they discuss the impact of the Inflation Reduction Act and other legislation and regulations in oncology, barriers around prior authorization, and more.
Klein also spoke with Alti Rahman, MHA, MBA, chief strategy and innovation officer at the American Oncology Network, about some similar topics, as well as his session on artificial and business intelligence (AI/BI) technology. In the interview, they explore the integration of AI in oncology while addressing ethical concerns, examine key factors in evaluating AI and BI solutions, and more.
The ACCC annual meeting kicked off with a session on organizational well-being, as well as deep dives into collaborative care delivery models and comprehensive cancer care. There were also a number of conversations on strategic collaborations within ACCC, updates and challenges in integrating electronic health records, and what oncology practices need to know to succeed under alternative payment models. You can check out more of this coverage on our website.
Read coverage and watch additional interviews from the meeting at AJMC.com.
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy
April 2nd 2025As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for managing specialty drug spending and polypharmacy risks, as showcased in recent research presented at the Academy of Managed Care Pharmacy 2025 conference.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy
April 2nd 2025Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.
Read More
The IRA’s Unintended Consequences for Drug Pricing and Coverage
April 2nd 2025The Inflation Reduction Act (IRA) may be restricting Medicare Part D formularies, increasing patient costs, and stifling pharmaceutical innovation, experts warned at the Academy of Managed Care Pharmacy 2025 annual meeting.
Read More